How does stress or trauma trigger or worsen prurigo nodularis?

Question

Hi doctor,

I am writing to seek urgent medical advice regarding my ongoing and severely debilitating skin condition, prurigo nodularis. It initially began as a few itchy spots on my shins but has now progressed to over 70 hard nodules spread across my entire body. The itching is so intense and relentless that I have been placed on disability leave from work.

The constant scratching has significantly damaged my skin, leaving it thickened and discolored. Some of the nodules have grown as large as grapes. I have consulted multiple dermatologists and undergone numerous treatments, including high-potency topical corticosteroids, intralesional steroid injections, phototherapy, and oral cyclosporine. Unfortunately, cyclosporine caused severe side effects, including uncontrollable tremors.

A recent skin biopsy confirmed prurigo nodularis with findings of “prominent neural hyperplasia,” which, I understand, may explain why antihistamines have had no effect in relieving the itch.

This condition began following a period of intense workplace stress and personal bereavement last year. I am a 45-year-old male and have now begun to exhibit signs of depression due to the constant itch–scratch cycle and severe sleep deprivation. I have not had more than three consecutive hours of sleep in several months.

The latest nodules have appeared on my neck and face, significantly affecting my self-esteem and causing social withdrawal. I have stopped meeting friends due to embarrassment over my appearance and the compulsive scratching.

My current dermatologist suggested initiating treatment with Dupilumab; however, my insurance provider denied coverage, stating that I have not yet exhausted all conventional therapies.

I am desperate for relief and would like to better understand the underlying pathophysiology of prurigo nodularis, specifically, why it is so resistant to treatment. Are there any newer or experimental therapies available that might be suitable in my case? I would also appreciate your guidance on whether this condition may have an autoimmune component, as I have a family history of thyroid disease.

Thank you for your time and attention. I look forward to your expert advice.

Please help me.

Answer 1

Hi,

Welcome to icliniq.com

I am truly sorry to hear that you are experiencing this. Prurigo nodularis (PN) can be an extremely distressing and life-altering condition.

What is happening in your body (explained in simple terms):

Nerve overgrowth: There is an overactivity of the skin’s nerve fibers, known medically as “prominent neural hyperplasia.” This leads to persistent itching sensations, even in the absence of an allergen or irritant.
Chronic scratching: The unrelenting itch results in frequent scratching. This scratching thickens the skin, forms hard nodules, and further aggravates the nerve endings, thus perpetuating a vicious itch-scratch cycle.
Immune system involvement: The immune system plays a significant role in this condition. It releases pro-inflammatory cytokines such as interleukin-4 (IL-4), interleukin-13 (IL-13), and interleukin-31 (IL-31), all of which exacerbate itch and inflammation.
Stress as a trigger: Emotional stress or trauma may intensify symptoms by sensitizing the interaction between the nervous system, the skin, and the immune system.

Why do many conventional treatments fail?

Antihistamines are ineffective because prurigo nodularis is not mediated by histamine, as is the case with typical allergic itching.
Topical or systemic corticosteroids and immunosuppressants such as cyclosporine are aimed at reducing inflammation, but they do not address the underlying neural hyperplasia or deeper immune dysregulation.
Phototherapy may provide partial relief, but it is often insufficient for long-term control.

Emerging and promising treatments:

Dupilumab (Dupixent): This monoclonal antibody targets IL-4 and IL-13, thereby reducing both inflammation and nerve irritation. It is now approved for the treatment of prurigo nodularis, although insurance providers frequently deny initial coverage.
Nemolizumab: This investigational therapy targets IL-31, a cytokine specifically involved in generating itch. It shows great promise and is currently undergoing the approval process.
Neuro-targeted medications: Agents such as gabapentin or pregabalin may help reduce nerve-driven itching in some patients.
Janus kinase (JAK) inhibitors: Medications like Upadacitinib and Ruxolitinib, which target deep immune signaling pathways, are under investigation for their potential benefits in prurigo nodularis.

Could prurigo nodularis be autoimmune in nature?

Yes, in certain cases. Prurigo nodularis is associated with other immune-mediated conditions, including:

Autoimmune thyroid disorders.
Atopic dermatitis, or eczema.
Systemic lupus erythematosus.
Diabetes mellitus.

Given your family history of thyroid disease, it would be advisable to assess thyroid function and screen for autoimmune markers if this has not already been done.

Mental health considerations:

The physical disfigurement, unrelenting itch, and chronic sleep deprivation associated with prurigo nodularis can lead to depression and anxiety. These psychological consequences are both valid and understandable responses to the condition.

Supportive measures such as sleep aids, psychological counseling, and participation in itch-specific patient support groups may provide emotional relief during the course of treatment.

Recommended actions you can take at present:

Request your physician to re-appeal the insurance denial for dupilumab or explore compassionate use and patient assistance programs for access to the medication.
If available, consider consulting a neurodermatologist or a specialist with expertise in chronic itch disorders.
Maintain a symptom diary to track flares in relation to mood, stress, or environmental triggers. Incorporating gentle mind-body interventions such as cognitive-behavioral therapy (CBT) or mindfulness techniques may also provide benefit in managing stress-induced itch.

I hope this information helps you.